Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02503696 · ClinicalTrials.gov registry record

Sample Collection Study to Evaluate DNA Markers in Subjects With Inflammatory Bowel Disease (IBD)

A clinical trial, sponsored by Exact Sciences Corporation.

Completed
Registry status
697
Enrollment target

NCT02503696: Completed study, sponsored by Exact Sciences Corporation.

NCT02503696 is a clinical trial that has completed, run by Exact Sciences Corporation. The registered enrollment target is 697 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02503696 has completed, sponsored by Exact Sciences Corporation.

COMPLETED
Registry status
697 participants
Enrollment target

Study Summary

The primary objective of this study is to gather stool samples from subjects with inflammatory bowel disease (IBD) to be added to a test set of stool samples that will be utilized to help select molecular markers and determine the optimal sensitivity and specificity values for the Exact IBD-ACRN surveillance test for colorectal cancer (CRC).

Primary Outcome

The primary endpoint is point estimates of the sensitivity of the diagnostic test for detection of colorectal cancer in IBD patients.

Interventions

  • DEVICE Stool Collection Kit

Trial Details

FieldValue
Enrollment Target 697 participants
Start Date 2014-09
Est. Completion 2016-06
Exact Sciences Corporation

30 total trials

What the finished NCT02503696 record still lists

NCT02503696 is an observational study that tracks outcomes without assigning an intervention. The registered 697 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 1 intervention - of which Stool Collection Kit is the first listed.

NCT02503696 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02503696 about?

NCT02503696 is a clinical study titled "Sample Collection Study to Evaluate DNA Markers in Subjects With Inflammatory Bowel Disease (IBD)". The primary objective of this study is to gather stool samples from subjects with inflammatory bowel disease (IBD) to be added to a test set of stool samples that will be utilized to help select molecular markers and determine the optimal sensitivity and specificity values for the Exact IBD-ACRN sur...

What is the current status of trial NCT02503696?

This trial is currently completed. The enrollment target is 697 participants. The study started on 2014-09. Estimated completion is 2016-06.

What interventions are being tested in trial NCT02503696?

The interventions under investigation include: Stool Collection Kit (DEVICE).

Who is sponsoring clinical trial NCT02503696?

This trial is sponsored by Exact Sciences Corporation, which has 30 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03136094 · 698 participants · NA

    Suicide in Urban Natives: Detection and Networks to Combat Events

  • NCT04928846 · 698 participants · Phase 3

    A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

  • NCT05943535 · 698 participants · Phase 3

    Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)

  • NCT07187115 · 699 participants · NA

    A Global Study Comparing Pulsed Field Ablation With Electrographic Flow Mapping Versus Posterior Wall Ablation for Persistent Atrial Fibrillation

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02503696, the US trial registry maintained by the National Library of Medicine. NCT02503696 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.